Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

<< Back to News

10/10/18 DC -- IV diphenhydramine

From: David Collette

To: grp allpharm

Sent: Wednesday, October 10, 2018 1:26:43 PM

Subject: IV diphenhydramine

 

 

We are still in the midst of a severe IV diphenhydramine shortage, with only a 2-3 week supply in stock. We need all pharmacists to take action on this now...

 

 

It is imperative that all patients who are ordered IV diphenhydramine for ANY reason other than a severe/anaphylactic reaction be switched to PO diphenhydramine. Please review Sentri-7 reports and profiles NOW and switch all possible patients to PO diphenhydramine.

 

 

I presented the shortage situation (and our handling of it) to MEC yesterday and they were 100% supportive of our actions, saying that we needed to do whatever is needed to keep a supply available for patients with severe reactions.

 

 

Thanks for your attention to and action on this request. DAVID

 

--

 

 

 

David R. Collette, Pharm.D., FASHP

Operations Manager, Professional Services Huntsville Hospital Department of Pharmacy






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved